US Bancorp’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.15M Sell
9,816
-4,003
-29% -$876K ﹤0.01% 833
2025
Q1
$3.09M Sell
13,819
-822
-6% -$184K ﹤0.01% 706
2024
Q4
$4.8M Sell
14,641
-3,220
-18% -$1.05M 0.01% 599
2024
Q3
$5.36M Sell
17,861
-1,028
-5% -$309K 0.01% 570
2024
Q2
$6.22M Sell
18,889
-1,029
-5% -$339K 0.01% 524
2024
Q1
$7.88M Sell
19,918
-1,818
-8% -$719K 0.01% 476
2023
Q4
$7.65M Sell
21,736
-93
-0.4% -$32.7K 0.01% 480
2023
Q3
$8.19M Sell
21,829
-162
-0.7% -$60.8K 0.01% 435
2023
Q2
$8.41M Sell
21,991
-3,709
-14% -$1.42M 0.01% 435
2023
Q1
$8.9M Sell
25,700
-17
-0.1% -$5.89K 0.02% 427
2022
Q4
$6.05M Sell
25,717
-8,119
-24% -$1.91M 0.01% 509
2022
Q3
$8.33M Sell
33,836
-593
-2% -$146K 0.02% 392
2022
Q2
$10.4M Sell
34,429
-3,919
-10% -$1.19M 0.02% 375
2022
Q1
$15.8M Sell
38,348
-341
-0.9% -$140K 0.03% 329
2021
Q4
$18.1M Buy
38,689
+645
+2% +$303K 0.03% 320
2021
Q3
$16.2M Sell
38,044
-1,071
-3% -$455K 0.03% 317
2021
Q2
$14M Buy
39,115
+892
+2% +$320K 0.03% 345
2021
Q1
$10.8M Buy
38,223
+1,646
+5% +$464K 0.02% 371
2020
Q4
$10.4M Buy
36,577
+3,411
+10% +$966K 0.02% 371
2020
Q3
$9.12M Buy
33,166
+5,792
+21% +$1.59M 0.02% 374
2020
Q2
$6.22M Sell
27,374
-143
-0.5% -$32.5K 0.02% 435
2020
Q1
$4.19M Sell
27,517
-623
-2% -$94.9K 0.01% 470
2019
Q4
$4.23M Buy
28,140
+1,017
+4% +$153K 0.01% 562
2019
Q3
$3.85M Buy
27,123
+327
+1% +$46.4K 0.01% 572
2019
Q2
$3.35M Buy
26,796
+1,866
+7% +$234K 0.01% 614
2019
Q1
$2.75M Buy
24,930
+1,803
+8% +$199K 0.01% 660
2018
Q4
$2.27M Buy
23,127
+3,034
+15% +$297K 0.01% 691
2018
Q3
$2.48M Buy
20,093
+2,252
+13% +$278K 0.01% 725
2018
Q2
$1.77M Buy
17,841
+1,826
+11% +$181K 0.01% 850
2018
Q1
$1.41M Buy
16,015
+7,996
+100% +$706K ﹤0.01% 936
2017
Q4
$792K Buy
8,019
+1,651
+26% +$163K ﹤0.01% 1222
2017
Q3
$613K Buy
6,368
+354
+6% +$34.1K ﹤0.01% 1322
2017
Q2
$569K Buy
6,014
+2,475
+70% +$234K ﹤0.01% 1350
2017
Q1
$289K Buy
3,539
+622
+21% +$50.8K ﹤0.01% 1636
2016
Q4
$247K Sell
2,917
-4
-0.1% -$339 ﹤0.01% 1701
2016
Q3
$218K Buy
2,921
+110
+4% +$8.21K ﹤0.01% 1720
2016
Q2
$213K Sell
2,811
-157
-5% -$11.9K ﹤0.01% 1696
2016
Q1
$206K Sell
2,968
-427
-13% -$29.6K ﹤0.01% 1671
2015
Q4
$205K Sell
3,395
-373
-10% -$22.5K ﹤0.01% 1695
2015
Q3
$204K Sell
3,768
-7,990
-68% -$433K ﹤0.01% 1729
2015
Q2
$683K Sell
11,758
-573
-5% -$33.3K ﹤0.01% 1200
2015
Q1
$743K Buy
12,331
+1,990
+19% +$120K ﹤0.01% 1162
2014
Q4
$550K Sell
10,341
-1,735
-14% -$92.3K ﹤0.01% 1297
2014
Q3
$540K Buy
12,076
+3,896
+48% +$174K ﹤0.01% 1284
2014
Q2
$345K Buy
8,180
+664
+9% +$28K ﹤0.01% 1541
2014
Q1
$332K Buy
7,516
+1,454
+24% +$64.2K ﹤0.01% 1524
2013
Q4
$298K Buy
6,062
+1,482
+32% +$72.9K ﹤0.01% 1537
2013
Q3
$188K Buy
4,580
+700
+18% +$28.7K ﹤0.01% 1714
2013
Q2
$136K Buy
+3,880
New +$136K ﹤0.01% 1851